Novartis Investigator Site

Buenos Aires

0 studies enrolling now · 2 studies all time

What they study most

Asthma, COPD, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed